Voice your opinion on congressional bill HR4619-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act

This bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.

House committee actions Actions

Committee
Oct. 09 2019	Referred to the Subcommittee on Health.
Oct. 08 2019	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Oct. 08
2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Oct. 08 2019	Introduced in House Introduced in House

House bill HR4619-116

Pharmaceutical REPAI Act

Promote the cause!

Or use this QR code